Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Barclays raised the price target for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) from $250 to $260. Barclays analyst Etzer Darout maintained an Overweight rating. Jazz Pharmaceuticals shares closed at $236.97 on Monday. See how other analysts view this stock.
Baird raised Affirm Holdings Inc (NASDAQ:AFRM) price target from $70 to $82. Baird analyst David Koning maintained a Neutral rating. Affirm shares closed at $81.93 on Monday. See how other analysts view this stock.
BTIG cut price target for Monday.Com Ltd (NASDAQ:MNDY) from $115 to $105. BTIG analyst Allan Verkhovskim maintained a Buy rating. Monday.Com shares closed at $86.84 on Monday. See how other analysts view this stock.
HC Wainwright & Co. cut the price target for NervGen Pharma Corp (NASDAQ:NGEN) from $18 to $15. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. NervGen Pharma shares closed at $1.93 on Monday. See how other analysts view this stock.
